These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27633807)

  • 1. Automated Processing of Dynamic Contrast-Enhanced MRI: Correlation of Advanced Pharmacokinetic Metrics with Tumor Grade in Pediatric Brain Tumors.
    Vajapeyam S; Stamoulis C; Ricci K; Kieran M; Poussaint TY
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):170-175. PubMed ID: 27633807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.
    Jung SC; Yeom JA; Kim JH; Ryoo I; Kim SC; Shin H; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH; Choi SH
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1103-10. PubMed ID: 24384119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
    You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric Analysis of Permeability and ADC Histogram Metrics for Classification of Pediatric Brain Tumors by Tumor Grade.
    Vajapeyam S; Brown D; Johnston PR; Ricci KI; Kieran MW; Lidov HGW; Poussaint TY
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):552-557. PubMed ID: 29301780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
    Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
    J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.
    Rochetams BB; Marechal B; Cottier JP; Gaillot K; Sembely-Taveau C; Sirinelli D; Morel B
    Neuroradiol J; 2017 Oct; 30(5):429-436. PubMed ID: 28556691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
    Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
    Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
    Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
    Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
    Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
    Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
    Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
    Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
    Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
    Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.
    Gupta PK; Saini J; Sahoo P; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Pediatr Neurosurg; 2017; 52(5):298-305. PubMed ID: 28848203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.
    Zhao W; Quan Z; Huang X; Ren J; Wen D; Zhang G; Shi Z; Yin H; Huan Y
    Oncol Lett; 2018 Jun; 15(6):8349-8356. PubMed ID: 29805568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of scan duration on dynamic contrast -enhanced magnetic resonance imaging pharmacokinetic parameters for brain lesions.
    Minosse S; Picchi E; Ferrazzoli V; Pucci N; Da Ros V; Giocondo R; Floris R; Garaci F; Di Giuliano F
    Magn Reson Imaging; 2024 Jan; 105():46-56. PubMed ID: 37939968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.